Clinical Trial Update: RotaTeq® and Meningococcus C Vaccine in Healthy Infants (V260-016) [Phase 3]

View source ↗

Summary

Phase 3 trial results for a combination vaccine regimen including RotaTeq and Meningococcus C vaccine in healthy infants; results were posted in June 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningococcal Meningitis
• Rotavirus Infection

Drugs mentioned

• Meningococcal C vaccine (Meningococcal C conjugate vaccine)
• RotaTeq (rotavirus vaccine, pentavalent)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Meningitis, Meningococcal, Rotavirus Infections | Phase 3 | Status: COMPLETED | Results posted: 2018-06-20